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We performed a controlled prospective study of pathologically verified sudden unexpected death in epilepsy (SUDEP) in a
coronial setting, to identify risk factors. We prospectively studied coronial deaths of people with epilepsy in Vic., Australia, during
a 21-month period. Fifty SUDEP and 50 subjects with epilepsy who died of other causes (controls) were collected sequentially.
Clinical data was obtained shortly after death from questionnaires completed by treating doctors, discussion with family members
and coronial files, including police reports of death, autopsy and toxicology reports. Factors assessed were age, sex, duration of
epilepsy, type of seizure(s), seizure frequency, symptomatic epilepsy, including post-traumatic epilepsy, presence of structural
brain lesion, idiopathic epilepsy, mental retardation, psychiatric illness, including dementia, recent stressful life event, particular
antiepileptic drugs (AEDs) and AED polytherapy, compliance with AED treatment, psychotropic drug prescription, alcohol and
other substance abuse, place of death and evidence of terminal seizure. The SUDEP group was characterised by younger age
and higher proportion found dead in bed and with evidence of terminal seizure compared to controls. The profile of patients at
risk for SUDEP are young people with epilepsy. They are most likely to die in sleep and our data support the view that SUDEP
is a seizure-related event. This, taken in conjunction with the finding that there was no increased risk associated with a particular
AED in monotherapy or multiple AEDs suggests that attempts to better treat patients’ epilepsy with AEDs might decrease the
risk of SUDEP. Although the literature suggests that SUDEP is more frequent in patients with severe epilepsy, we did not find
a correlation with seizure frequency suggesting that other clinical indices may be more important.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
People with epilepsy have an increased incidence of
sudden unexpected death (SUDEP)1–6. Estimates of
SUDEP incidence vary. In population-based studies,
the SUDEP rate is generally between 1:500 and 1:1000
per year7–14. For those with severe epilepsy, the rate
of SUDEP is approximately 1:200 per year15–27.
Evidence for terminal seizure is found in a variable
proportion of cases. However, the best circumstantial
evidence seems to favour that most cases are seizure
related11, 21, 28–30. Mechanisms postulated to play a
role in SUDEP include cardiac arrhythmia precipitated
by seizure discharge acting via the autonomic nervous
system31–38, respiratory arrest39–41, neurogenic pul-
monary oedema42, 43 and asphyxiation29, 41, 44, 45.
Previous studies have suggested a number of asso-
ciated factors but results are not completely consistent
between studies. These include young age8, 11, 12, 14,
19, 21, 23, 24, 29, 30, 46–53
, male sex9, 13, 14, 27, 29, 46, 48, 50–52,
generalised tonic–clonic seizures8, 11, 23, 24, 46, 47, 50,
51, 54
, low11, 14, 47 or high seizure frequency16, 18–21, 23–
27, 46, 55, 56
, chronic epilepsy11, 14, 47, 54, symptomatic
epilepsy23, 57, 58, structural brain lesion23, 57, 58, post-
traumatic epilepsy23, 57, 58, early onset epilepsy44, 56,
mental retardation14, 51, 54, 59–63, recent unusu-
ally stressful life event46, particular antiepileptic
drugs (AEDs)27, 46, increasing number of AEDs
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prescribed 13, 54, 56, 64, poor compliance with AED
treatment8, 11, 12, 30, 48, 50–52, 65–68, psychotropic drug
prescription, including anxiolytic use13, 50, 56, alco-
hol8, 11–13, 50, 51, 67 and sleep21, 23, 30, 46, 50, 66, 68–70.
Most previous studies, however, have not been con-
trolled and the significance of such associated factors
remains uncertain.
We performed a prospective controlled study of risk
factors for SUDEP in a coronial population in Vic.,
Australia. We concentrated on risk factors suggested
by previous investigators.
METHODS
Study population
The Victorian Institute of Forensic Medicine pro-
vides forensic pathology services for approximately
4 million people. The population base for this study
was deaths that occurred in Vic., Australia, that were
reported to the coroner and autopsied between De-
cember 1997 and August 1999. This included deaths
(a) for which a death certificate was not completed as
the doctor was not sure of the cause of death, (b) that
were unexpected, unnatural or violent or resulted di-
rectly or indirectly from accident or injury, (c) that
were of people held compulsorily in institutions as
they or their families were unable to look after them,
(d) of persons whose identity was unknown, and
(e) that occurred during or as a result of an anaesthetic
and were not due to natural causes. Deaths due to nat-
ural causes referred to deaths that resulted from inher-
ent disease, such as ischemic heart disease as opposed
to deaths due to accident, suicide or homicide. The
average yearly population for Victoria was 4 674 467.
The annual mortality rate was 7.0 per 1000 popula-
tion (source Australian Bureau of Statistics). Coronial
autopsies accounted for 9% of the total number of
deaths for Victoria over this period. Approval for this
study was given by the Victorian Institute of Forensic
Medicine Ethics Committee.
Cases
We identified cases as follows: police reports of
death were searched for subjects with a history of
epilepsy. We defined SUDEP according to the crite-
ria of Nashef71. With few exceptions, the autopsies
in this study were performed by and the brains had
formal neuropathologic examination by the one neu-
ropathologist (KO). Control subjects were those with
a history of epilepsy who died from other causes.
Fifty SUDEP and 50 control subjects were collected
sequentially and not matched in any way other than
for assessment period.
Assessment of clinical variables
Questionnaires were sent to treating doctors request-
ing information shortly after the death. Information
sought included age at seizure onset, cause, seizure
type(s) and frequency, neurological examination,
diagnostic tests, treatment and AED compliance, re-
cent AED medication changes, general medical and
psychiatric history, intellectual disability, non-AED
treatment, alcohol and other substance abuse, re-
cent life stresses and family history. The treating
doctors were asked to classify seizure type as gen-
eralised tonic–clonic/grand mal, partial simple or
complex, myoclonic, multiple or unknown. Psy-
chiatric history requested included detail of severe
depression, desire to commit suicide, schizophre-
nia, violent behaviour and behavioural disorders.
Doctors were asked to indicate whether compliance
with AED treatment was good or poor (based on
detail of medication usage and ante-mortem AED
levels). Psychotropic drug prescription history re-
quested included the use of antipsychotic drugs and
antidepressants.
Family members were also spoken to, requesting in-
formation on alcohol and other substance abuse, com-
pliance with AED treatment, recent stressful life event,
whether the deceased was found dead, where the body
was found, whether terminal seizure was witnessed
and whether there was urinary incontinence or distur-
bance of bed clothes (indicating terminal seizure) at
the scene. When data from the treating doctor was in
conflict with information from the subjects family, an
assessment was made as to which was reliable. The
data that was considered to be reliable was accepted.
Where conflict remained the clinical variable was clas-
sified as not known.
Police reports of death giving details of the circum-
stances surrounding the death and the scene of death,
and autopsy and post-mortem toxicology reports were
also examined. Evidence at the scene for unwitnessed
terminal seizure was considered to include the body
being found half on, half off the bed or wrapped up
in sheets, urinary incontinence and bruising of lips or
tongue at autopsy.
The probable etiology of epilepsy was finally de-
termined on the basis of clinical details and brain
examination at autopsy. Epilepsy was classified as
idiopathic epilepsy in those who had been devel-
opmentally normal, had no significant neurological
abnormalities and had no known underlying cause
for epilepsy. Epilepsy was classified as symptomatic
epilepsy in those with known underlying cerebral,
metabolic or genetic disorder and in those in whom
this was suspected from the findings of intellectual
deficiency and/or significant abnormal neurological
abnormalities72.
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Analysis
Given the reasonably large number of subjects and
the possible correlations between some variables, the
question of multivariate versus univariate statistical
analysis was carefully considered. Ultimately, the na-
ture of the data, including heteroscedasticity and skew
(see below), which would have resulted in very small
numbers in some cells, led to the decision to use uni-
variate analyses. Non-parametric method were used
when necessary. Statistical analysis using Student’s
t-tests, chi-square analysis and Mann–Whitney U-test
was performed. Levene’s test for homogeneity of vari-
ance was met for all variables with the exception of
age and seizure frequency. For these two variables
the assumption of equal variance was violated (F =
5.22, P = 0.024 and F = 8.14, P = 0.006, respec-
tively), so separate variance estimates were used to
calculate Student’s t-tests of the difference between
the means of two independent groups. In the case of
seizure frequency, violation of equality of variance
was so marked that Mann–Whitney U-test was run in
order to check the findings of t-test. Regarding com-
Table 1: Causes of death in the control group.
Cause of death Number of cases (n = 50)
Natural
Cardiovascular
Ischemic heart disease 11
Valvular heart disease 1
Congenital heart disease 1
Other (combined ischemic and valvular disease, ruptured abdominal
aortic aneurysm, myocarditis, cardiomyopathy)
4
Respiratory
Pneumonia 6
Pulmonary thrombolism 2
Central nervous system
Hypoxic brain damage 1
Other
Combined pneumonia ischemic and valvular disease, bowel cancer and
pneumonia, multiorgan organ system failure, sepsis
4
Subtotal 30
Accidental
Heroin 5
Motor vehicle 2
Head injury/falls 3
Drowning 2
Fire 2
Airway obstruction 3
Subtotal 17
Suicide
Combined drug toxicity 2
Multiple injuries (train) 1
Subtotal 3
parison of numbers of subjects found dead in bed in
the SUDEP and control groups for assessment of sleep
as a risk factor, subjects who were already in a hos-
pital bed were excluded as many of these found dead
in bed may have been false positives.
RESULTS
Demography
There were 4375 coronial autopsies between Decem-
ber 1997 and August 1999, of which 166 were epilep-
tic deaths. These epileptic deaths included those in
which there was a history of epilepsy and the people
had died from accidents, such as drowning, suicide,
unsuspected unnatural disease and SUDEP. Of these
epileptic deaths 50 (30%) were SUDEPs. The causes
of death in the control group are shown in Table 1. Us-
ing an estimate of prevalence of epilepsy in Victoria
of 0.5% and an average yearly population of 4 674 467
(source Australian Bureau of Statistics), the incidence
of SUDEP was approximately 1:780 per year.
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The age of the SUDEP subjects ranged from 4 to
71 years and the control subjects 3 to 78 years. The
SUDEP group was significantly younger than the con-
trol (mean 34.6 ± 13.0 SD vs. 40.9 ± 17.8 years).
There were five subjects less than 18 years of age in
the SUDEP group versus four in the control.
In the SUDEP group, 54% were male, 46% female
and in the control group 78% male, 22% female.
Chi-square analysis indicated the proportion of fe-
males to males was greater in the SUDEP group
compared with the control group (χ2 = 6.54, df = 1,
0.02 > P > 0.01). Of the nine traumatic or suicide
deaths in the control group, six were male.
Clinical features
There was no difference in the average duration of
epilepsy between SUDEP and control groups (mean =
16.8± 13.0 SD vs. 18.8± 17.3). Twenty-three of 40
SUDEPs and 20 of 46 controls had early onset epilepsy
(onset 0–15 years) and 1 of 40 SUDEPs and 7 of
46 controls had onset of epilepsy after 45 years. The
Table 2: Type of seizures in SUDEP and control groups.
Type of Seizure SUDEPs Controls
(n = 50) (n = 50)
GTC 30 27
Partial 3 5
Multiple 16 15
GTC and partial 11 9
GTC, partial, absence 1 0
GTC, absence 3 4
GTC, partial, myoclonic, absence 1 0
GTC, myoclonic 0 1
GTC, partial, myoclonic 0 1
Absence 0 2
Unknown 1 1
GTC: generalised tonic–clonic seizure.
Table 3: Aetiology of epilepsy in SUDEP and control groups.
Aetiology of epilepsy SUDEPs Controls
(n = 50) (n = 50)
ILAE classification
Symptomatic/cryptogenic epilepsy 34 37
Idiopathic epilepsy 5 8
Not known 11 5
Post-traumatic epilepsy
Previous head trauma 8 6
No head trauma 42 43
Not known 0 1
Structural brain lesion
Structural lesion 22 28
No lesion 28 21
Not known 0 1
ILAE: International League Against Epilepsy.
types of seizures (Table 2) and aetiology (Table 3) in
SUDEP and control groups were similar.
The mean number of seizures between SUDEP and
control groups was not significantly different (mean =
20.9±10.4 SD vs. 6.5±1.3 SD, t = 1.37, df = 39.2,
P = 0.178). The variance between the two groups
was significantly different, consistent with a subgroup
of the SUDEP group having an unduly large number
of seizures. Four of 50 SUDEPs and 0 of 50 con-
trols had greater than 50 seizures per year whereas 15
SUDEPs and 21 controls had less than 2 seizures per
year (Table 4).
The neuropsychiatric features in SUDEP and control
groups are shown in Table 5. In particular, psychiatric
illness was not more common in the SUDEP group
(χ2 = 2.8, df = 1, ns). Mental retardation, dementia
and recent unusually stressful life event were not more
common in the SUDEP group.
Table 4: Frequency of seizures in SUDEP and control
groups.
Seizure frequency
(per year)
SUDEPs (n = 50) Controls (n = 50)
<2 15 21
2–10 18 8
10–20 2 8
20–30 0 5
30–40 0 0
40–50 1 0
>50 4 (∼=130, 900, 350,
180 seizures per year)
0
Unknown 10 8
Mean ± SDa 20.9 ± 10.4 6.5 ± 1.3
a ns.
Table 5: Neuropsychiatric features in SUDEP and control
groups.
Neuropsychiatric features SUDEPs Controls
(n = 50) (n = 50)
Mental retardation
Yes 17 23
No 26 23
Not known 7 4
Psychiatric illnessa
Yes 12 20
No 33 26
Not known 5 4
Dementia
Yes 0 3
No 44 45
Not known 6 2
Recent stressful life event
Yes 21 19
No 26 25
Not known 3 6
a ns.
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Table 6: Antiepileptic drug prescription in SUDEP and
control groups.
Number and type of AEDs SUDEPs Controls
(n = 50) (n = 50)
Number of AEDs
No drug 7 4
One drug 17 25
Two drugs 13 14
Three drugs 10 4
Four drugs 3 2
Unknown 0 1
Type of AED
Carbamazepine 16 23
Sodium valproate 18 21
Clonazepama 9 4
Lamotrigine 9 8
Phenytoina 20 15
Phenobarbitone 2 2
Gabapentin 2 1
Vigabatrin 0 3
Diazepam 1 3
Ethosuximide 0 1
Clobazam 3 0
Topiramate 1 0
Primidone 2 2
Not known 0 1
AED: antiepileptic drug.
a ns.
Medication details
The total number of cases receiving single, dual,
triple or quadruple AED therapy is shown in Table 6.
No AED or combination was more common in the
SUDEP group. The proportion of SUDEP cases on
single, dual, triple or quadruple AED treatment did
not differ from the control sample. There was also
no difference between the two groups in relation to
clonazepam (χ2 = 0.9, df = 1, ns) or phenytoin
prescription (χ2 = 0.3, df = 1, ns).
Compliance with AED treatment is shown in
Table 7. Poor compliance (based on treating doctors’
assessment of medication usage and AED levels and
assessment by family members) was not more com-
mon in the SUDEP group.
Psychotropic drug prescription was not more com-
mon in the SUDEP group. In particular, thioridazine
use was not more common in the SUDEP group
Table 7: Compliance with antiepileptic drug treatment in
SUDEP and control groups.
Compliance SUDEPs Controls
(n = 50) (n = 50)
Poor 11 11
Good 32 33
Not on AED treatment 4 3
Not known 3 3
AED: antiepileptic drug.
Table 8: Psychotropic drug prescription in SUDEP and
control groups.
Number of psychotropic drugs SUDEPs Controls
(n = 50) (n = 50)
No drug 35 31
One drug 9 12
Two drugs 3 2
Not known 3 5
Type of psychotropic drug SUDEPs Controls
Thioridazinea 4 1
Sertraline 2 2
Paroxetine 2 1
Clozapine 1 0
Haloperidol 1 2
Trifluoperazine 2 0
Clomipramine 1 1
Chlorpromazine 2 1
Fluoxetine 0 3
Respiridone 0 2
Olanzipine 0 1
Doxepin 0 1
Fluphenazine 1 0
Haloperidol 0 1
Not known 5
a ns.
Table 9: Alcohol and other substance abuse in SUDEP and
control groups.
Alcohol abuse SUDEPs Controls
(n = 50) (n = 50)
Yes 8 8
No 42 42
Non-alcohol substance abuse
Yes 5 11
No 43 38
Not known 2 1
(χ2 = 0.8, df = 1, ns). Anxiolytic use was signifi-
cantly less common in the SUDEP group (2/48 cases
vs. 8/45 cases in the control group) (χ2 = 4.34,
df = 1, P < 0.05). Nitrazepam use was not more
common in the SUDEP group (0/46 cases vs. 3/45
cases in the control group) (Table 8).
Alcohol and other substance abuse was not more
common in the SUDEP group (Table 9).
Death details
More of the SUDEP group were found dead in bed at
home (χ2 = 8.1, df = 3, 0.05 > P > 0.02) and evi-
dence of terminal seizure was significantly more com-
mon in the SUDEP group (χ2 = 9.4, df = 3, 0.05 >
P > 0.02) (Table 10). Six SUDEPs were witnessed
and seizure occurred in all of these. Three deaths in
the control group were witnessed and a seizure was
witnessed in one of these. There was no significant
difference between the number of witnessed deaths,
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Table 10: Numbers found dead in bed and showing
evidence of terminal seizure in SUDEP and control groups.
Death details SUDEPs Controls
(n = 50) (n = 50)
Place of death
Hospital bed 2 11
Home beda 24 16
Not found in bed 24 22
Not known 0 1
Evidence for terminal seizure
Yesa 22 8
No 15 22
Not known 13 20
a More common in SUDEP group.
and the number of seizures in witnessed deaths in the
SUDEP group versus control group (χ2 = 3.0, df =
1, 0.10 > P > 0.05).
DISCUSSION
Previous data on associated-risk factors for SUDEP
has come from selected series of subjects from
centres for patients with severe epilepsy, epilepsy
referral centres, coroners’ offices or larger cohort
studies. To date, there have only been a small num-
ber of controlled studies looking at risk factors
for SUDEP9, 19, 27, 44, 54, 56, 70. Although controlled,
these studies have had some limitations. These in-
clude: (1) virtually all were retrospective, limiting
the amount/quality of information available73, 74. (2)
In some, the number of SUDEP cases was relatively
small9, 27, 54. (3) SUDEP was not defined in one
study27. (4) Autopsies were not done in some cases
classified as SUDEP/probable SUDEP19, 54, 56, 70. (5)
Some, by design, looked at only a limited number
of risk factors19, 70. (6) Some studies included or ex-
cluded epilepsy cases on the basis of AED prescription
(thereby possibly missing some SUDEP cases)9, 56.
In our study, we compared suggested risk fac-
tors in SUDEPs with epileptics dying from other
causes in a coronial population. Such an approach
has strengths and limitations compared to previous
controlled studies. The strengths are that every case
met rigorous criteria for SUDEP, including autopsy,
the number of cases relative to previous controlled
studies9, 19, 27, 44, 56, 70 was large and data on epilepsy
and a wide range of potential risk factors was col-
lected from treating doctors and family members
shortly after death. The limitations relate to how rep-
resentative the non-SUDEP deaths are of the general
population of people with epilepsy. It is likely that
this population has an over-representation of severe
epilepsy and psychiatric problems. Although a rep-
resentative living control group would be preferable,
ascertainment issues and the difficulty in collecting
clinical data in a uniform manner from deceased and
living subjects made such an approach impossible.
Our study was not primarily an epidemiological one
but our estimate of SUDEP of approximately 1:780
epileptics per year is in keeping with SUDEP rates
as estimated from population-based studies7, 9–14.
It is lower than rates estimated by most cohort
studies15–21, 23–26, 55 probably because our population
had fewer subjects with severe epilepsy. Our estimate
may still be an underestimate as it is likely some
SUDEPs were not referred to the coroner. Also, once
cases have been reported to the coroner, some family
members object to autopsy on potential SUDEP cases
and these objections may be upheld by the coroner.
Our finding that the SUDEP group was significantly
younger than the control is in keeping with most pre-
vious studies that indicated young adults are partic-
ularly at risk of SUDEP8, 11, 12, 14, 19, 23, 24, 29, 30, 46–53.
This finding may relate to the definition of SUDEP,
viz. in elderly people it may not be possible to diag-
nose SUDEP due to the presence of anatomic disease
that could be capable of causing death. This limita-
tion of the definition of SUDEP, however, affects all
SUDEP research. Our finding of the SUDEP group be-
ing younger than the controls was not accounted for by
there being a greater number of children in the SUDEP
group compared with the control (five SUDEPs less
than 18 years of age vs. four controls).
Our finding of a slight male predominance in the
SUDEP group (27 males and 23 females) is consis-
tent with a number of studies3, 7, 8, 21, 23, 40, 42, 44–46,
although some found no sex difference6, 75. Our con-
trol group contained more males. This bias was only
partly explained by the expected male predominance
in trauma and suicide deaths and we were not able to
satisfactorily, completely explain this finding.
Our finding of long duration of epilepsy in the
SUDEP group is in keeping with most previous
studies11, 12, 14, 24, 29, 46, 47, 50, 51, but there was no dif-
ference in duration between SUDEP and control
groups. This finding of no difference in duration be-
tween SUDEP and control groups is in keeping with
three previous studies9, 27, 44, but contrasts with an-
other which reported shorter duration of epilepsy in
the SUDEP compared with the non-SUDEP group19.
Our finding that early onset epilepsy was not in-
creased in the SUDEP group agreed with one9, but
differed from another two which found increased risk
with early onset epilepsy compared with late onset
epilepsy44, 56. None of the SUDEP cases had absence
or myoclonic seizures alone, and virtually all had gen-
eralised tonic–clonic seizures in agreement with previ-
ous studies8, 11, 23, 46, 47, 50, 54, although the distribution
of seizure types was not different in our control group.
Most studies suggest that SUDEP occurs more com-
monly in those with frequent seizures16, 18–21, 23–27, 46,
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55, 56
, but some like our study find no association
between SUDEP and difficult to control seizure
disorders/seizure frequency9, 27, 44, 51. The lack of
association with frequent seizures may relate to an
over-representation of severe epilepsy in our controls,
but it is noteworthy that 30% of our SUDEP cases had
less than 2 seizures per year emphasising that SUDEP
can occur in subjects with rare seizures. However, a
subgroup of our SUDEP cases had very high seizure
frequency. We also did not confirm the finding of
some studies that polytherapy with AEDs13, 54, 56, 64
(which may be a surrogate for seizure frequency) was
a risk factor for SUDEP.
We did not confirm previous reports of association
of SUDEP with psychotropic drug prescription13, 50, 56
and did not find an association with psychiatric ill-
ness. Although possible over-representation of sub-
jects with severe psychiatric illness in our coronial
control group compared with the general epileptic
population could account for our finding that psychi-
atric illness/psychotropic drug prescription was not in-
creased in the SUDEP group, it is notable that our
finding regarding psychotropic drug prescription was
in keeping with two other controlled studies44, 54.
We did not confirm previous reports of association
of SUDEP with particular epilepsies8, 11, 23, 24, 46, 47, 50,
51, 54
, with mental retardation9, 11, 13, 18, 23, 24, 50, 54,
recent stressful life event46 or alcohol abuse8, 11–13, 50,
51, 67
, with particular AEDs27, 46, increasing number of
AEDs prescribed13, 54, 56, 64 or compliance8, 11, 12, 30, 48,
50–52, 65–68
. A lack of adequate controls and highly
selected case series in previous studies probably
account for these differences11–13, 18, 23, 24, 46, 51, 66, 67.
The profile of patients at risk for SUDEP are young
people with epilepsy. They are most likely to die dur-
ing sleep, and SUDEP, should it occur, is a seizure-
related event. Although a small proportion of SUDEP
cases had very frequent seizures, our finding that
seizure frequency was overall not greater than controls
suggests other indices of epilepsy control or of other
clinical characteristics may be more important. Such
indices might be seizure duration, nocturnal seizures
or peculiarities of the autonomic nervous system lead-
ing to a fatal cardio-respiratory response even to rare
seizures. This, taken in conjunction with the finding
that there was no increased risk associated with a
particular AED in monotherapy or multiple AEDs
suggests that attempts to better treat patients’ epilepsy
with AEDs might decrease the risk of SUDEP.
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